Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways
- PMID: 37739320
- PMCID: PMC10616760
- DOI: 10.1016/j.taap.2023.116694
Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways
Abstract
Oxidative stress and insulin resistance are two key mechanisms for the development of diabetic cardiomyopathy (DCM, cardiac remodeling and dysfunction). In this review, we discussed how zinc and metallothionein (MT) protect the heart from type 1 or type 2 diabetes (T1D or T2D) through its anti-oxidative function and insulin-mediated PI3K/Akt signaling activation. Both T1D and T2D-induced DCM, shown by cardiac structural remodeling and dysfunction, in wild-type mice, but not in cardiomyocyte-specific overexpressing MT mice. In contrast, mice with global MT gene deletion were more susceptible to the development of DCM. When we used zinc to treat mice with either T1D or T2D, cardiac remodeling and dysfunction were significantly prevented along with increased cardiac MT expression. To support the role of zinc homeostasis in insulin signaling pathways, treatment of diabetic mice with zinc showed the preservation of phosphorylation levels of insulin-mediated glucose metabolism-related Akt2 and GSK-3β and even rescued cardiac pathogenesis induced by global deletion of Akt2 gene in a MT-dependent manner. These results suggest the protection by zinc from DCM is through both the induction of MT and sensitization of insulin signaling. Combined our own and other works, this review comprehensively summarized the roles of zinc homeostasis in the development and progression of DCM and its therapeutic implications. At the end, we provided pre-clinical and clinical evidence for the preventive and therapeutic potential of zinc supplementation through its anti-oxidative stress and sensitizing insulin signaling actions. Understanding the intricate connections between zinc and DCM provides insights for the future interventional approaches.
Keywords: Cardiac dysfunction; Diabetic cardiomyopathy; Diabetic heart; Heart failure; Trace metals; Zinc.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing fiscal interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10616760/bin/nihms-1937047-f0001.gif)
![Fig. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10616760/bin/nihms-1937047-f0002.gif)
![Fig. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10616760/bin/nihms-1937047-f0003.gif)
![Fig. 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/10616760/bin/nihms-1937047-f0004.gif)
Similar articles
-
Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice.J Cell Mol Med. 2021 Jul;25(14):6828-6840. doi: 10.1111/jcmm.16687. Epub 2021 May 30. J Cell Mol Med. 2021. PMID: 34053181 Free PMC article.
-
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.Cardiovasc Diabetol. 2021 Jan 4;20(1):2. doi: 10.1186/s12933-020-01188-0. Cardiovasc Diabetol. 2021. PMID: 33397369 Free PMC article. Review.
-
Metallothionein Preserves Akt2 Activity and Cardiac Function via Inhibiting TRB3 in Diabetic Hearts.Diabetes. 2018 Mar;67(3):507-517. doi: 10.2337/db17-0219. Epub 2017 Oct 27. Diabetes. 2018. PMID: 29079702 Free PMC article.
-
Zinc rescue of Akt2 gene deletion-linked murine cardiac dysfunction and pathological changes is metallothionein-dependent.J Mol Cell Cardiol. 2014 Sep;74:88-97. doi: 10.1016/j.yjmcc.2014.04.023. Epub 2014 May 10. J Mol Cell Cardiol. 2014. PMID: 24819347
-
Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.Curr Med Chem. 2007;14(20):2193-203. doi: 10.2174/092986707781389646. Curr Med Chem. 2007. PMID: 17691957 Review.
Cited by
-
Fe-Zn alloy, a new biodegradable material capable of reducing ROS and inhibiting oxidative stress.Regen Biomater. 2024 Jan 12;11:rbae002. doi: 10.1093/rb/rbae002. eCollection 2024. Regen Biomater. 2024. PMID: 38404619 Free PMC article.
-
Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid.World J Diabetes. 2023 Dec 15;14(12):1717-1720. doi: 10.4239/wjd.v14.i12.1717. World J Diabetes. 2023. PMID: 38222784 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous